China’s patent office has upheld the validity of Symrise’s SymSave H multifunctional, antioxidant, and product protectant enhancer ingredient technology.
The China National Intellectual Property Administration (CNIPA) decision secures Symrise's exclusive rights to utilize and commercialize SymSave H technology in China.
CNIPA's decision follows a rigorous review process, including bilateral invalidation proceedings, and it confirms the SymSave H technology meets China's strict patent criteria, including novelty, inventiveness, and clear disclosure.
This enhances the patent's value and strengthens Symrise's competitive edge.
With hydroxyacetophenone as its INCI, SymSave H helps extend product shelf life, reduce oxidation even for sensitive skin.
“The confirmation of Chinese Patent CN’216 highlights CNIPA's commitment to a thorough and impartial review process,” said Sven Siegel, Global Director Intellectual Properties at Symrise.
“This ensures only patents with genuine merit are upheld,” he added.
